MOFILET 250MG TABLET

Mofilet 250 mg Tablet is an immunosuppressant with an active ingredient known as Mycophenolate mofetil. It falls under the inosine-monophosphate dehydrogenase (IMPDH) inhibitor class. The medicine is used to stop organ rejection in people who have had the organs of a donor (such as heart, kidney, and liver transplantation). It is usually prescribed as a part of a combination treatment, which includes other immunosuppressive medications.
The use of this drug is not recommended during pregnancy because of the risk of miscarriage and congenital disabilities. It is not recommended during pregnancy unless there are no other alternatives and the advantages outweigh the risks. Women of childbearing age are strongly advised to take effective contraceptives while taking this tablet to avoid pregnancies. Live vaccines shouldn’t be administered while a patient is taking Mofilet 250 mg Tablet due to the reduced effectiveness and risk of developing infection. Patients taking this medication must not give blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug is entirely cleared from the body before blood is donated.
It is usually advised not to take this drug if you are allergic to the medication or other components. Inform your doctor about heart or liver disease before starting the treatment. Since this medication weakens the body’s immune system, it could increase the risk of developing skin cancer. People should take steps to minimize their exposure to the ultraviolet (UV) ultraviolet (UV) light. Consult your physician immediately if you experience any bleeding on the skin, a fever, or any other unidentified tiredness, dizziness, discoloration of the skin, eyes, or vision impairment, a decrease in urine output, or seizures following this medication. Mofilet 250 mg Tablet is an immunosuppressive drug. It could affect infants’ developing immune systems and should not be used during breastfeeding. In some instances, alternatives to medications that have more safety-related benefits while breastfeeding might be thought of as.